Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
31.47
+1.06 (3.49%)
At close: Jan 21, 2026, 4:00 PM EST
31.50
+0.03 (0.10%)
After-hours: Jan 21, 2026, 4:00 PM EST
Forte Biosciences Market Cap
Forte Biosciences has a market cap or net worth of $561.69 million as of January 21, 2026. Its market cap has increased by 247.67% in one year.
Market Cap
561.69M
Enterprise Value
468.28M
1-Year Change
247.67%
Ranking
Category
Stock Price
$31.47
Market Cap Chart
Since June 16, 2020, Forte Biosciences's market cap has increased from $181.43M to $561.69M, an increase of 209.59%. That is a compound annual growth rate of 22.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 542.25M | 11.51% |
| Dec 31, 2025 | 486.26M | 234.91% |
| Dec 31, 2024 | 145.19M | 386.30% |
| Dec 29, 2023 | 29.86M | 42.17% |
| Dec 30, 2022 | 21.00M | -33.49% |
| Dec 31, 2021 | 31.57M | -93.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Keros Therapeutics | 561.49M |
| Alpha Tau Medical | 550.81M |
| Replimune Group | 549.89M |
| LB Pharmaceuticals | 543.93M |
| CorMedix | 542.07M |
| Alto Neuroscience | 541.18M |
| Design Therapeutics | 538.31M |
| Lexeo Therapeutics | 529.89M |